SBTi Registry
Explore 1 matching companies with public, verified Science Based Targets commitments.
Data sourced from the Science Based Targets initiative (SBTi).
| Sector | Region | Near-Term Status | Size | ||||
|---|---|---|---|---|---|---|---|
| GSK | Pharmaceuticals, Biotechnology and Life Sciences | Europe | Targets set | Large | 5 | Nov 16, 2023 | |
Near-Term Status Targets set Near-Term Classification 1.5°C Near-Term Target Year 2030 Long-Term Status Targets set Net-Zero Status Targets set Net-Zero Year 2045 Sector Pharmaceuticals, Biotechnology and Life Sciences Region Europe Organization Type Corporate Location United Kingdom Company Size Large Target Statement Overall Net-Zero Target GSK commits to reach net-zero greenhouse gas emissions across the value chain by 2045 from a 2020 base year. Near-Term Targets GSK commits to reduce absolute scope 1 and 2 GHG emissions 80% by 2030 from a 2020 base year.* GSK also commits to reduce absolut… Stakeholders Global VP, Sustainability Giulia Usai Senior Director Procurement Sustainability Senior Manager Sustainability Procurement Senior Manager-Procurement Sustainability Chief Procurement Officer | |||||||
Turn Commitments Into Impact
Thousands of companies have set public Scope 3 emissions-reduction targetsthrough SBTi, but few have the tools to deliver on them. Carbon3 gives you the infrastructure to plan, track, and execute the supply-chain decarbonization work behind your commitment, turning a public pledge into measurable progress. See how it works.